Alpha 2.0
Login Register
» Articles » PMID: 36319936

Nephrology Picture: Bone Loss Due to Absence of Adequate Therapy for Severe Secondary Hyperparathyroidism

Overview
Journal J Nephrol
Publisher Springer
Specialty Nephrology
Date 2022 Nov 2
PMID 36319936
Authors
Eduardo J Duque
Rosilene M Elias
Vanda Jorgetti
Rosa M A Moyses
Affiliations
Soon will be listed here.
Citing Articles

The role of osteopontin and osteocyte-derived factors in secondary hyperparathyroidism-induced myopathy.

Duque E, Crispilho S, Oliveira I, Dominguez W, Silva C, Furukawa L JBMR Plus. 2024; 8(8):ziae084.

PMID: 39070237 PMC: 11273725. DOI: 10.1093/jbmrpl/ziae084.

References
1.
Duque E, Elias R, Moyses R . Parathyroid Hormone: A Uremic Toxin. Toxins (Basel). 2020; 12(3). PMC: 7150960. DOI: 10.3390/toxins12030189. View
2.
Araujo M, Karohl C, Elias R, Barreto F, Barreto D, Canziani M . The pitfall of treating low bone turnover: Effects on cortical porosity. Bone. 2016; 91:75-80. DOI: 10.1016/j.bone.2016.07.009. View
3.
Pessoa M, Santo R, de Deus A, Duque E, Rochitte C, Moyses R . Corneal and Conjunctival Calcification in a Dialysis Patient Reversed by Parathyroidectomy. Blood Purif. 2020; 50(2):254-256. DOI: 10.1159/000508804. View
4.
Goto N, Tominaga Y, Matsuoka S, Sato T, Katayama A, Haba T . Cardiovascular complications caused by advanced secondary hyperparathyroidism in chronic dialysis patients; special focus on dilated cardiomyopathy. Clin Exp Nephrol. 2005; 9(2):138-41. DOI: 10.1007/s10157-005-0351-1. View